Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

romifidine

Known as: N-(2-bromo-6-fluorophenyl)-4,5-dihydro-(1H)-imidazol-2-amine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
OBJECTIVE To evaluate and compare the antinociceptive effects of the three alpha-2 agonists, detomidine, romifidine and xylazine… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVE To study the analgesic potency of the alpha2-agonist romifidine in the horse using both an electrical current and a… Expand
Is this relevant?
2001
2001
A technique of transrectal ultrasonography was developed to investigate the effects of romifidine 80 and 120 microg/kg bwt on… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The effects of two intravenous doses of romifidine (80 and 120 μg/kg) and one dose of detomidine (20 μg/kg) were compared in a… Expand
Is this relevant?
1999
1999
To test the hypothesis that pulmonary alterations are more important than hemodynamic changes in alpha2-agonist-induced hypoxemia… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1997
Highly Cited
1997
In the present study, the hypoxaemic potential of four alpha 2 agonists possessing different selectivity for alpha 2… Expand
Is this relevant?
1996
1996
The purpose of this study was to compare and evaluate sedation with intravenous xylazine (1.1 mg/kg bodyweight [BW]) versus… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
In a double blind study, eight horses were treated intravenously at seven-day intervals with detomidine at doses of 10, 20 and 40… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The sedative effects of a new alpha 2-adrenoceptor agonist, romifidine, were compared with those of xylazine and detomidine. Five… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
SUMMARY The behavioural and sedative effects of intravenous (iv) romifidine (40 and 80 μg/kg bodyweight [bwt]) alone or in… Expand
Is this relevant?